Y-27632 dihydrochloride

Y-27632 dihydrochloride

Contact us: [email protected]

Y-27632 dihydrochloride

GK8578-25MG 25 mg
EUR 945.6

Y-27632 dihydrochloride

GK8578-5MG 5 mg
EUR 399.6

Y-27632 (dihydrochloride)

HY-10583 50mg
EUR 349.2

Y 27632

20-abx076548
  • EUR 326.40
  • EUR 627.60
  • 1 mg
  • 5 mg

Y-27632

B1293-10 10 mg
EUR 170.4
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

B1293-200 200 mg
EUR 1284
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

B1293-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

B1293-50 50 mg
EUR 505.2
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

E1KS1049 2 mg
EUR 390

Y-27632

HY-10071 100mg
EUR 1480.8

EZSolution? Y-27632

1784-5
EUR 535.2

EZSolution? Y-27632, Sterile-Filtered

1994-1
EUR 430.8

Y 27632 (ROCK kinase inhibitor)

SIH-486-1MG 1 mg
EUR 178.8
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

Y 27632 (ROCK kinase inhibitor)

SIH-486-5MG 5 mg
EUR 393.6
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

Y-39983 dihydrochloride

B1176-10 10 mg
EUR 494.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride

B1176-100 100 mg
EUR 2881.2
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride

B1176-5 5 mg
EUR 320.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride

B1176-50 50 mg
EUR 1796.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-33075 (dihydrochloride)

HY-10069 5mg
EUR 258

SNRPF Polyclonal Antibody

27632-100ul 100ul
EUR 302.4

SNRPF Polyclonal Antibody

27632-50ul 50ul
EUR 224.4

Vatalanib Dihydrochloride

2025-25
EUR 366

Vatalanib Dihydrochloride

2025-5
EUR 151.2

1400W dihydrochloride

2055-25
EUR 405.6

1400W dihydrochloride

2055-5
EUR 151.2

GGACK Dihydrochloride

1847-5 5 mg
EUR 382.8
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

PPACK Dihydrochloride

1848-5
EUR 301.2

Puromycin Dihydrochloride

1860-100
EUR 326.4

Puromycin Dihydrochloride

1860-1000
EUR 1554

Puromycin Dihydrochloride

1860-25
EUR 151.2

Puromycin Dihydrochloride

1860-250
EUR 548.4

Puromycin Dihydrochloride

1860-500
EUR 966

Emetine dihydrochloride

1970-250
EUR 430.8

Emetine dihydrochloride

1970-50
EUR 164.4

Norquetiapine dihydrochloride

2362-250
EUR 496.8

Norquetiapine dihydrochloride

2362-50
EUR 170.4

Antipain dihydrochloride

2834-25
EUR 392.4

Antipain dihydrochloride

2834-5
EUR 144

Dorsmorphin dihydrochloride

2835-25
EUR 705.6

Dorsmorphin dihydrochloride

2835-5
EUR 222

Berbamine dihydrochloride

2520-100
EUR 157.2

Berbamine dihydrochloride

2520-500
EUR 444

GGACK Dihydrochloride

A2582-5 5 mg
EUR 282
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

PPACK Dihydrochloride

A2588-10 10 mg
EUR 423.6
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM.

PPACK Dihydrochloride

A2588-25 25 mg
EUR 908.4
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM.

PPACK Dihydrochloride

A2588-5 5 mg
EUR 265.2
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM.

AT7867 dihydrochloride

A3199-10 10 mg
EUR 408
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-100 100 mg
EUR 2210.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-5 5 mg
EUR 320.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-5.1 10 mM (in 1mL DMSO)
EUR 344.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-50 50 mg
EUR 1537.2
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

Canertinib dihydrochloride

A3276-10 10 mg
EUR 129.6
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Canertinib dihydrochloride

A3276-100 100 mg
EUR 226.8
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Canertinib dihydrochloride

A3276-50 50 mg
EUR 177.6
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Inolitazone dihydrochloride

A3499-5 5 mg
EUR 837.6
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma.

Alexidine dihydrochloride

A4542-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells.

Alexidine dihydrochloride

A4542-50 50 mg
EUR 220.8
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells.

Vatalanib Dihydrochloride

20-abx076544
  • EUR 309.60
  • EUR 594.00
  • 10 mg
  • 50 mg

DMPQ Dihydrochloride

20-abx076714
  • EUR 693.60
  • EUR 326.40
  • 25 mg
  • 5 mg

H89 Dihydrochloride

20-abx076747
  • EUR 811.20
  • EUR 360.00
  • 25 mg
  • 5 mg

LDK378 dihydrochloride

A3544-10 10 mg
EUR 186
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-100 100 mg
EUR 331.2
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-5 5 mg
EUR 150
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-5.1 10 mM (in 1mL H2O)
EUR 184.8
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-50 50 mg
EUR 240
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

Mibefradil dihydrochloride

A3605-10 10 mg
EUR 315.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride

A3605-25 25 mg
EUR 663.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride

A3605-5 5 mg
EUR 201.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride

A3605-50 50 mg
EUR 1195.2
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Pramipexole dihydrochloride

A3733-20 20 mg
EUR 129.6
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Pramipexole dihydrochloride

A3733-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Pramipexole dihydrochloride

A3733-50 50 mg
EUR 157.2
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Retigabine dihydrochloride

A3758-10 10 mg
EUR 164.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-100 100 mg
EUR 522
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-5 5 mg
EUR 126
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-50 50 mg
EUR 325.2
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Veliparib dihydrochloride

A3958-10 10 mg
EUR 177.6
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-200 200 mg
EUR 1002
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-5 5 mg
EUR 150
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-5.1 10 mM (in 1mL DMSO)
EUR 139.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-50 50 mg
EUR 421.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Piperazine Dihydrochloride

abx180858-100g 100 g
EUR 276

Pramipexole dihydrochloride

20-abx180860
  • EUR 543.60
  • EUR 276.00
  • EUR 444.00
  • 10 g
  • 1 g
  • 5 g

IT1t dihydrochloride

B5650-10 10 mg
EUR 385.2
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-100 100 mg
EUR 2100
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-25 25 mg
EUR 710.4
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-5 5 mg
EUR 243.6
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-5.1 10 mM (in 1mL DMSO)
EUR 261.6
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-50 50 mg
EUR 1232.4
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

Cystamine dihydrochloride

B5785-5.1 10 mM (in 1mL DMSO)
EUR 129.6

Cystamine dihydrochloride

B5785-50 50 mg
EUR 134.4

Fluphenazine dihydrochloride

B6132-100 100 mg
EUR 180
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons.

Fluphenazine dihydrochloride

B6132-5.1 10 mM (in 1mL DMSO)
EUR 201.6
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons.

Dilazep dihydrochloride

B6316-50 50 mg
EUR 321.6

Dimaprit dihydrochloride

B6328-100 100 mg
EUR 321.6

Naloxonazine dihydrochloride

B6366-10 10 mg
EUR 265.2

Naloxonazine dihydrochloride

B6366-50 50 mg
EUR 926.4

Piribedil dihydrochloride

B6557-10 10 mg
EUR 166.8

Piribedil dihydrochloride

B6557-100 100 mg
EUR 258

Piribedil dihydrochloride

B6557-200 200 mg
EUR 404.4

Piribedil dihydrochloride

B6557-5.1 10 mM (in 1mL DMSO)
EUR 180

Piribedil dihydrochloride

B6557-50 50 mg
EUR 223.2

Piribedil dihydrochloride

B6557-500 500 mg
EUR 675.6

Pirenzepine dihydrochloride

B6582-100 100 mg
EUR 160.8

Pirenzepine dihydrochloride

B6582-5.1 10 mM (in 1mL DMSO)
EUR 180

Pirenzepine dihydrochloride

B6582-500 500 mg
EUR 219.6

Telenzepine dihydrochloride

B6606-10 10 mg
EUR 193.2

Telenzepine dihydrochloride

B6606-50 50 mg
EUR 576

DMPQ dihydrochloride

B6642-10 10 mg
EUR 223.2

DMPQ dihydrochloride

B6642-5 5 mg
EUR 184.8

GNTI dihydrochloride

B6669-10 10 mg
EUR 459.6

GNTI dihydrochloride

B6669-50 50 mg
EUR 1746

1400W dihydrochloride

B6730-10 10 mg
EUR 170.4
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

1400W dihydrochloride

B6730-100 100 mg
EUR 873.6
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

1400W dihydrochloride

B6730-50 50 mg
EUR 525.6
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

Rimcazole dihydrochloride

B6765-10 10 mg
EUR 388.8

Rimcazole dihydrochloride

B6765-50 50 mg
EUR 1453.2

Zimelidine dihydrochloride

B6851-10 10 mg
EUR 212.4

Zimelidine dihydrochloride

B6851-50 50 mg
EUR 711.6

MPP dihydrochloride

B6910-10 10 mg
EUR 381.6

MPP dihydrochloride

B6910-50 50 mg
EUR 1413.6

Linopirdine dihydrochloride

B6916-10 10 mg
EUR 327.6

Linopirdine dihydrochloride

B6916-5 5 mg
EUR 224.4

Mizolastine dihydrochloride

B1116-100 100 mg
EUR 285.6
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Mizolastine dihydrochloride

B1116-200 200 mg
EUR 468
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Mizolastine dihydrochloride

B1116-500 500 mg
EUR 783.6
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Flupenthixol dihydrochloride

B7578-50 50 mg
EUR 154.8
Description: MIC: 10-100 ?g/mL in most of the strainsFlupenthixol, introduced in 1965 by Lundbeck, marketed under brand names such asDepixol.Flupenthixolis atypical antipsychoticdrugof thethioxantheneclass.

Puromycin dihydrochloride

B7587-5.1 10 mM (in 1mL H2O)
EUR 142.8
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA.

Puromycin dihydrochloride

B7587-50 50 mg
EUR 157.2
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA.

Dexpramipexole dihydrochloride

B2215-25
EUR 548.4

Dexpramipexole dihydrochloride

B2215-5
EUR 183.6

Daclatasvir dihydrochloride

B2224-25
EUR 496.8

Daclatasvir dihydrochloride

B2224-5
EUR 170.4

Netarsudil dihydrochloride

B2387-25
EUR 548.4

Netarsudil dihydrochloride

B2387-5
EUR 183.6

Furamidine dihydrochloride

B2581-25
EUR 652.8

Furamidine dihydrochloride

B2581-5
EUR 210

Bisantrene dihydrochloride

B2736-25 25 mg
EUR 576

Bisantrene dihydrochloride

B2736-5 5 mg
EUR 199.2

Cystamine dihydrochloride

B2982-1 1 g
EUR 132

Cystamine dihydrochloride

B2982-5 5 g
EUR 351.6

Cetirizine dihydrochloride

B2993-100 100mg
EUR 132

Cetirizine dihydrochloride

B2993-500 500mg
EUR 344.4

Y-27632 dihydrochloride